Israel Active

Israel’s MeMed Diagnostics (see previously) has received US FDA clearance for its MeMed BV blood test that can distinguish, in minutes, between bacterial and viral infections. It can help prevent the inappropriate use of antibiotics that leads to antimicrobial resistance (AMR).

Useful webinar on coronavirus mutations and the booster shots from two leading Ben Gurion University experts - Prof. Nadav Davidovitch, M.D., Ph.D., M.P.H., and Dr. Anat Rosenthal, Ph.D.

Doctors and nurses currently serving in the IDF have commenced the “Hand-in-hand” initiative. Coronavirus patients are transferred from hospital to home-based care. They are monitored remotely from a command center, with at least once-a-day on-site visits from medical personnel.

Israeli-managed Code Pharma developed its Codivir treatment for HIV at its Israeli R&D center. It has just completed a successful Phase 1 trial in Brazil for using Codivir against the coronavirus and has applied to start a Phase 2 trial on 150 patients in Israel, Spain, Brazil and South Africa.

The Chair of UK’s Health and Social Care Select Committee, MP Jeremy Hunt, stated in Parliament that Israel shows that a booster program reduces Covid hospitalizations in just two weeks. Israeli research also shows that the booster gives 10 times more antibodies than the second jab.

Very Good news. Surgeons at Israel’s Soroka hospital used Israeli technology to separate the heads and major blood vessels of two conjoined Israeli baby girls, assisted by a UK Muslim specialist. The babies were visibly delighted to be able to see each other for the first time.

The U.S.’s largest life insurer company New York Life has partnered Israel’s Empathy (see previously) The Israeli app will help guide NYL customers navigate the complexities experienced with loss by offering logistics and emotional support.

Israel’s Eleos Health has developed an AI-powered voice analysis system to help behavioral health clinicians and care teams provide better personalized, care to mental health patients and reduce staff burnout.  It is deployed at Solvista Health, Achieve, Yeshiva University and ReachLink.

Tel Aviv University scientists have discovered more on the effects of Hyperbaric Oxygen Therapy (HBOT – see ). It significantly improved vascular function and blood flow to the brain, plus reduced and removed the build-up of amyloid plaque on the brain – a common symptom of Alzheimer’s.

Israel’s SpliSense (see previously) uses mRNA to fix the root cause of cystic fibrosis - genetic mutations that create a non-functioning protein (CFTR). It not only treats patients with no current treatment but is also much cheaper than existing treatments.